Bath & Body Works Stock Falls After Goldman Sachs Downgrade

By EC Assets · Published 8 July 2026

Bath & Body Works experienced a stock decline following a downgrade from Goldman Sachs. The investment bank lowered its price target for the company, indicating reduced expectations for future upside. This downgrade reflects a lagging market sentiment for the stock. Goldman Sachs adjusted its price target for Bath & Body Works to $19. This revision suggests that Wall Street analysts perceive less potential for growth in the company's stock value. The negative sentiment contributes to the downward pressure on shares. Bath & Body Works shares are part of the S&P 400 index. The company has a consensus rating of Hold, based on analyst recommendations. The average rating score is 2.11, with 3 buy ratings and 14 other ratings, but notably no strong buy ratings. The stock previously saw an increase of 7.2% since its last earnings report. Market analysts have listed Bath & Body Works among companies making headlines in premarket trading. This article is intended for informational purposes only. It does not constitute investment advice.